
Adam Jackson
Staff Reporter at Green Market Report
Reporter @greenmarketrpt | Email me at [email protected]
Articles
-
1 week ago |
greenmarketreport.com | Adam Jackson
The Minnesota Office of Cannabis Management announced Monday that its final cannabis rules have been published in the state register, officially putting them into effect after receiving approval from an administrative law judge earlier this month. “The adoption of rules is the most significant step to launching the cannabis market because the office cannot issue business licenses until they are in place,” Interim Director Eric Taubel said in a statement.
-
1 week ago |
greenmarketreport.com | Adam Jackson
Rhode Island’s Cannabis Control Commission voted Friday to approve a comprehensive set of regulations that will govern the state’s recreational marijuana market, according to the Rhode Island Current. The new rules clear the way for the expansion of retail operations nearly two and a half years after legalization. “These are truly homegrown, just like our cultivators,” Commission Chairperson Kimberly Ahern said following the panel’s vote.
-
1 week ago |
greenmarketreport.com | Adam Jackson
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) reported fourth quarter revenue of $6.6 million for the period ending Dec. 31, 2024, concluding a year of some stability in the Canadian biopharmaceutical company’s commercial ventures. The Toronto-based cannabinoid-focused achieved $25.5 million in annual revenue, a 52% rise from 2023. Still, it posted a fourth-quarter net loss of $440,094, a significant improvement versus the $2.4 million loss reported in the same quarter of 2023, according to filings.
-
1 week ago |
greenmarketreport.com | Adam Jackson
A Philadelphia judge upheld a nearly $24.5 million award to a cannabis entrepreneur who claimed her business partners fraudulently induced her to reduce her ownership stake in a marijuana company without disclosing it was about to be sold for millions, Law360 first reported.
-
2 weeks ago |
greenmarketreport.com | Adam Jackson
MindBio Therapeutics Corp. (Frankfurt: WF6) (CSE: MBIO) on Friday announced a new financing package that includes a private placement and substantial debt settlements to help strengthen its cash position. The company plans to raise up to $170,000 via a non-brokered private placement of 15.45 million common shares priced at $0.011 per share, according to a news release.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 413
- Tweets
- 365
- DMs Open
- Yes

Real music. Forever.

FREE 🪷 new song out now! Enjoy x 🥹 https://t.co/IhpE1mSsSh https://t.co/AF0kzMax4T

RT @WallandBroad: @GreenMarketRpt and @adam_sjackson are staying on top of the #Texas #hemp news. Subscribe now. Only $49 for 12 months. Le…

RT @FCHWPO: Iftar dinner with the Somali fam 🐐